openPR Logo
Press release

Antidiabetic Drug Market Global Industry Analysis 2018 – 2025

06-28-2018 08:45 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: WISE GUY RESEARCH CONSULTANTS PVT LTD

/ PR Agency: Wise Guy Research Consultants Pvt Ltd
Global Antidiabetic Drug Industry

Global Antidiabetic Drug Industry

Global Antidiabetic Drug Industry

New Study on “2018-2025 Antidiabetic Drug Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

This report studies the global Antidiabetic Drug market status and forecast, categorizes the global Antidiabetic Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Antidiabetic Drug market is valued at 49600 million US$ in 2017 and will reach 96700 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.

The major manufacturers covered in this report 
Sanofi-Aventis 
Eli Lilly 
Oramed 
Takeda 
Boehringer Ingelheim 
Novo Nordisk 
Halozyme Therapeutics 
Bristol-Myers Squibb 
Pfizer 
Tonghua Dongbao 
Biocon 
Wockhardt

Try Sample Report @    https://www.wiseguyreports.com/sample-request/3219955-global-antidiabetic-drug-market-research-report-2018

Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug 
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period. 
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas. 
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India

We can also provide the customized separate regional or country-level reports, for the following regions: 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Rest of Asia-Pacific 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Rest of Europe 
Central & South America 
Brazil 
Argentina 
Rest of South America 
Middle East & Africa 
Saudi Arabia 
Turkey 
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Alpha-Glucosidase Inhibitors 
Biguanides, Sulphonylureas 
Glp-1 Agonist 
Meglitinides 
Dpp-4 Inhibitors 
Sglt–2 
Thiazolodinediones 
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Type I Diabetes 
Type II Diabetes

The study objectives of this report are: 
To analyze and study the global Antidiabetic Drug sales, value, status (2013-2017) and forecast (2018-2025). 
Focuses on the key Antidiabetic Drug manufacturers, to study the sales, value, market share and development plans in future. 
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. 
To define, describe and forecast the market by type, application and region. 
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. 
To identify significant trends and factors driving or inhibiting the market growth. 
To analyze the opportunities in the market for stakeholders by identifying the high growth segments. 
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market 
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antidiabetic Drug are as follows: 
History Year: 2013-2017 
Base Year: 2017 
Estimated Year: 2018 
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders 
Antidiabetic Drug Manufacturers 
Antidiabetic Drug Distributors/Traders/Wholesalers 
Antidiabetic Drug Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

Available Customizations 
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: 
Regional and country-level analysis of the Antidiabetic Drug market, by end-use. 
Detailed analysis and profiles of additional market players.

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3219955-global-antidiabetic-drug-market-research-report-2018

Some points from table of content:

Global Antidiabetic Drug Market Research Report 2018 
1 Antidiabetic Drug Market Overview 
1.1 Product Overview and Scope of Antidiabetic Drug 
1.2 Antidiabetic Drug Segment by Type (Product Category) 
1.2.1 Global Antidiabetic Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Antidiabetic Drug Production Market Share by Type (Product Category) in 2017 
1.2.3 Alpha-Glucosidase Inhibitors 
1.2.4 Biguanides, Sulphonylureas 
1.2.5 Glp-1 Agonist 
1.2.6 Meglitinides 
1.2.7 Dpp-4 Inhibitors 
1.2.8 Sglt–2 
1.2.9 Thiazolodinediones 
1.3 Global Antidiabetic Drug Segment by Application 
1.3.1 Antidiabetic Drug Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Type I Diabetes 
1.3.3 Type II Diabetes 
1.4 Global Antidiabetic Drug Market by Region (2013-2025) 
1.4.1 Global Antidiabetic Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Antidiabetic Drug (2013-2025) 
1.5.1 Global Antidiabetic Drug Revenue Status and Outlook (2013-2025) 
1.5.2 Global Antidiabetic Drug Capacity, Production Status and Outlook (2013-2025)

2 Global Antidiabetic Drug Market Competition by Manufacturers 
2.1 Global Antidiabetic Drug Capacity, Production and Share by Manufacturers (2013-2018) 
2.1.1 Global Antidiabetic Drug Capacity and Share by Manufacturers (2013-2018) 
2.1.2 Global Antidiabetic Drug Production and Share by Manufacturers (2013-2018) 
2.2 Global Antidiabetic Drug Revenue and Share by Manufacturers (2013-2018) 
2.3 Global Antidiabetic Drug Average Price by Manufacturers (2013-2018) 
2.4 Manufacturers Antidiabetic Drug Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Antidiabetic Drug Market Competitive Situation and Trends 
2.5.1 Antidiabetic Drug Market Concentration Rate 
2.5.2 Antidiabetic Drug Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

3 Global Antidiabetic Drug Capacity, Production, Revenue (Value) by Region (2013-2018) 
3.1 Global Antidiabetic Drug Capacity and Market Share by Region (2013-2018) 
3.2 Global Antidiabetic Drug Production and Market Share by Region (2013-2018) 
3.3 Global Antidiabetic Drug Revenue (Value) and Market Share by Region (2013-2018) 
3.4 Global Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.5 North America Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.6 Europe Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.7 China Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.8 Japan Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.9 Southeast Asia Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
3.10 India Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Antidiabetic Drug Supply (Production), Consumption, Export, Import by Region (2013-2018) 
4.1 Global Antidiabetic Drug Consumption by Region (2013-2018) 
4.2 North America Antidiabetic Drug Production, Consumption, Export, Import (2013-2018) 
4.3 Europe Antidiabetic Drug Production, Consumption, Export, Import (2013-2018) 
4.4 China Antidiabetic Drug Production, Consumption, Export, Import (2013-2018) 
4.5 Japan Antidiabetic Drug Production, Consumption, Export, Import (2013-2018) 
4.6 Southeast Asia Antidiabetic Drug Production, Consumption, Export, Import (2013-2018) 
4.7 India Antidiabetic Drug Production, Consumption, Export, Import (2013-2018)

5 Global Antidiabetic Drug Production, Revenue (Value), Price Trend by Type 
5.1 Global Antidiabetic Drug Production and Market Share by Type (2013-2018) 
5.2 Global Antidiabetic Drug Revenue and Market Share by Type (2013-2018) 
5.3 Global Antidiabetic Drug Price by Type (2013-2018) 
5.4 Global Antidiabetic Drug Production Growth by Type (2013-2018)

6 Global Antidiabetic Drug Market Analysis by Application 
6.1 Global Antidiabetic Drug Consumption and Market Share by Application (2013-2018) 
6.2 Global Antidiabetic Drug Consumption Growth Rate by Application (2013-2018) 
6.3 Market Drivers and Opportunities 
6.3.1 Potential Applications 
6.3.2 Emerging Markets/Countries

7 Global Antidiabetic Drug Manufacturers Profiles/Analysis 
7.1 Sanofi-Aventis 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Antidiabetic Drug Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 Sanofi-Aventis Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 Eli Lilly 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Antidiabetic Drug Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Eli Lilly Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 Oramed 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Antidiabetic Drug Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Oramed Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Takeda 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Antidiabetic Drug Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Takeda Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 Boehringer Ingelheim 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Antidiabetic Drug Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Boehringer Ingelheim Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018) 
7.5.4 Main Business/Business Overview 
7.6 Novo Nordisk 
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.6.2 Antidiabetic Drug Product Category, Application and Specification 
7.6.2.1 Product A 
7.6.2.2 Product B 
7.6.3 Novo Nordisk Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.6.4 Main Business/Business Overview 
7.7 Halozyme Therapeutics 
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.7.2 Antidiabetic Drug Product Category, Application and Specification 
7.7.2.1 Product A 
7.7.2.2 Product B 
7.7.3 Halozyme Therapeutics Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.7.4 Main Business/Business Overview 
7.8 Bristol-Myers Squibb 
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.8.2 Antidiabetic Drug Product Category, Application and Specification 
7.8.2.1 Product A 
7.8.2.2 Product B 
7.8.3 Bristol-Myers Squibb Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.8.4 Main Business/Business Overview 
7.9 Pfizer 
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.9.2 Antidiabetic Drug Product Category, Application and Specification 
7.9.2.1 Product A 
7.9.2.2 Product B 
7.9.3 Pfizer Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.9.4 Main Business/Business Overview 
7.10 Tonghua Dongbao 
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.10.2 Antidiabetic Drug Product Category, Application and Specification 
7.10.2.1 Product A 
7.10.2.2 Product B 
7.10.3 Tonghua Dongbao Antidiabetic Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2020) 
7.10.4 Main Business/Business Overview 
7.11 Biocon 
7.12 Wockhardt

8 Antidiabetic Drug Manufacturing Cost Analysis 
8.1 Antidiabetic Drug Key Raw Materials Analysis 
8.1.1 Key Raw Materials 
8.1.2 Price Trend of Key Raw Materials 
8.1.3 Key Suppliers of Raw Materials 
8.1.4 Market Concentration Rate of Raw Materials 
8.2 Proportion of Manufacturing Cost Structure 
8.2.1 Raw Materials 
8.2.2 Labor Cost 
8.2.3 Manufacturing Expenses 
8.3 Manufacturing Process Analysis of Antidiabetic Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers 
9.1 Antidiabetic Drug Industrial Chain Analysis 
9.2 Upstream Raw Materials Sourcing 
9.3 Raw Materials Sources of Antidiabetic Drug Major Manufacturers in 2017 
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders 
10.1 Marketing Channel 
10.1.1 Direct Marketing 
10.1.2 Indirect Marketing 
10.1.3 Marketing Channel Development Trend 
10.2 Market Positioning 
10.2.1 Pricing Strategy 
10.2.2 Brand Strategy 
10.2.3 Target Client 
10.3 Distributors/Traders List

Continued…….

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antidiabetic Drug Market Global Industry Analysis 2018 – 2025 here

News-ID: 1101219 • Views: 178

More Releases from WISE GUY RESEARCH CONSULTANTS PVT LTD

Automotive IoT Market 2020 : Key Players – Google, Apple, OnStar, Cisco System …
Automotive IoT Industry Description Wiseguyreports.Com Adds “Automotive IoT -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database Understanding the market, on-going changes, and future aspects are of paramount importance when it comes to expanding the business from global to bigger scales. This report on the global Automotive IoT market is a full set of data required by any market player to understand the market’s movement.
Energy and Sport Drinks Market 2020: Key Players – Lucozade, Pepsico, Coca Col …
Energy and Sport Drinks Industry Description Wiseguyreports.Com Adds “Energy and Sport Drinks -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database The report of Energy and Sport Drinks market on the Wise Guy Report (WGR) website is highly accurate. The data is prepared by deploying modern market research methods. Proficient market research analysts used bottom-up approach to study the Energy and Sport Drinks market. A
Concentrated Solar Power (CSP) Market 2020 : Key Players –BrightSource Energy, …
Concentrated Solar Power (CSP) Industry Description Wiseguyreports.Com Adds “Concentrated Solar Power (CSP) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database The report of Concentrated Solar Power (CSP) market on the Wise Guy Report (WGR) website is highly accurate. The data is prepared by deploying modern market research methods. Proficient market research analysts used bottom-up approach to study the Concentrated Solar Power (CSP) market. A
Fake Eyelashes Market 2020 : Key Players – Ardell, ESQIDO, Elf, Kiss, Revlon, …
Fake Eyelashes Industry Description Wiseguyreports.Com Adds “Fake Eyelashes -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database The report of Fake Eyelashes market on the Wise Guy Report (WGR) website is highly accurate. The data is prepared by deploying modern market research methods. Proficient market research analysts used bottom-up approach to study the Fake Eyelashes market. A comprehensive assessment of the Fake Eyelashes market was

All 5 Releases


More Releases for Antidiabetic

Global Antidiabetic Thiazolidinediones Market Strategies and Forecasts, 2017 to …
Report Overview: The “Global Antidiabetic Thiazolidinediones Market Research Report” is a professional and in-depth study on the current state of the Antidiabetic Thiazolidinediones Market. The study offers an insight into current and future market trends, key drivers and restraints, market strategies of key market players along with detailed segmentation and forecast. The study offers industry overview by covering basic aspects such as product definition and classification, market size and share of
Oral Antidiabetic (OAD) Treatment Market Snapshot by 2017 – 2025
Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. The world is moving toward
Antidiabetic Biosimilars Market Expected to Grow Globally
Antidiabetic biosimilars market overview Antidiabetics help control blood glucose levels in diabetic patients. Various types of antidiabetics include biguanides, thiazolidinediones, DPP-IV inhibitors, α-glucosidase Inhibitors, sulfonylureas, insulin, and GLP-1 receptor agonists such as exenatide. A biosimilar product is biological product that is approved on the basis that it is highly similar to a FDA approved biological product known as a reference product. Biosimilar manufacturers need to generate data from lab testing and
03-07-2017 | Health & Medicine
SA-BRC
Antidiabetic Drugs Market and Pipeline Assessment
Diabetes is a major lifestyle disorder affecting millions of individuals globally. The disorder is also linked with other complications such as diabetic retinopathy, diabetic foot ulcers, nephropathy and cardiovascular complications among others. Wide spread global prevalence and rising incidence rate has made the antidiabetic drugs market attractive for pharmaceutical drug manufacturers. Introduction of superior products in the recent past and increasing patient compliance are other factors driving the diabetes treatment
Global Antidiabetic Thiazolidinediones Market Research Report 2017
The research report on the global Antidiabetic Thiazolidinediones market studies the market in the past based on which estimates are presented for the future. The report looks into vital market indicators, trends, and opportunities that will have a bearing on the development of this market. The report begins with an outline of terms and terminologies, classifications, and applications that are standard conventions in the global Antidiabetic Thiazolidinediones market. A glance into
Antidiabetic Biosimilars Market, Company Analysis and Forecast to 2024
Antidiabetic biosimilars market overview Antidiabetics help control blood glucose levels in diabetic patients. Various types of antidiabetics include biguanides, thiazolidinediones, DPP-IV inhibitors, α-glucosidase Inhibitors, sulfonylureas, insulin, and GLP-1 receptor agonists such as exenatide. A biosimilar product is biological product that is approved on the basis that it is highly similar to a FDA approved biological product known as a reference product. Biosimilar manufacturers need to generate data from lab testing and